Trade

with

Taro Pharmaceutical Industries Ltd
(NYSE: TARO)
AdChoices
145.97
+0.90
+0.62%
After Hours :
146.10
+0.13
+0.09%

Open

145.50

Previous Close

145.07

Volume (Avg)

97.87k (101.12k)

Day's Range

145.10-147.63

52Wk Range

76.40-165.30

Market Cap.

6.25B

Dividend Rate ( Yield )

-

Beta

0.60

Shares Outstanding

42.83M

P/E Ratio (EPS)

18.38 (7.94)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 759.28M

    • Net Income

    • 360.39M

    • Market Cap.

    • 6.25B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 47.22

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.60

    • Forward P/E

    • -

    • Price/Sales

    • 8.68

    • Price/Book Value

    • 5.78

    • Price/Cash flow

    • 19.42

      • EBITDA

      • 461.99M

      • Return on Capital %

      • 27.63

      • Return on Equity %

      • 34.56

      • Return on Assets %

      • 27.63

      • Book Value/Share

      • 25.23

      • Shares Outstanding

      • 42.83M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -15.00

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • 34.90

          • -26.33

          • Net Income

            Q/Q (last year)

          • -21.50

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 17.27

          • -5.42

          • Net Income

            5-Year Annual Average

          • 60.10

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 75.87

            • 64.72

            • Pre-Tax Margin

            • 56.91

            • 13.77

            • Net Profit Margin

            • 47.22

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.01

              • 0.33

              • Current Ratio

              • 4.37

              • 1.52

              • Quick Ratio

              • 3.86

              • 0.87

              • Interest Coverage

              • 219.36

              • 6.77

              • Leverage Ratio

              • 1.25

              • 1.91

              • Book Value/Share

              • 25.23

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 18.38

                • 63.69

                • P/E Ratio 5-Year High

                • 20.80

                • 237.47

                • P/E Ratio 5-Year Low

                • 0.96

                • 19.71

                • Price/Sales Ratio

                • 8.68

                • 3.64

                • Price/Book Value

                • 5.78

                • 3.39

                • Price/Cash Flow Ratio

                • 19.42

                • 21.79

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 34.56

                    (-)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • 27.63

                    (-)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • 33.93

                    (-)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • 259.08k

                  • 27.79k

                  • Inventory Turnover

                  • 1.48

                  • 1.80

                  • Asset Turnover

                  • 0.59

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  430.25M
                  Operating Margin
                  56.67
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  19.42
                  Ownership

                  Institutional Ownership

                  80.18%

                  Top 10 Institutions

                  74.40%

                  Mutual Fund Ownership

                  1.55%

                  Float

                  31.13%

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Hotchkis & Wiley Small Cap Value Fund

                  •  

                    180,700

                  • -10.19

                  • 0.42

                  • RAM (Lux) Sys Emg Mkts Equities

                  •  

                    66,262

                  • 10.96

                  • 0.15

                  • Hotchkis & Wiley Value Opps Fd

                  •  

                    39,700

                  • -20.92

                  • 0.09

                  • Pru Ret Small Cap Value/Kennedy SP

                  •  

                    38,187

                  • 1.95

                  • 0.09

                  • Schroder Diversified Growth Fd

                  •  

                    36,200

                  • 0.00

                  • 0.08

                  • Omega ConsensUS International Equity Fd

                  •  

                    32,500

                  • 2.52

                  • 0.08

                  • Undrly Schroder Life QEP Global Quality

                  •  

                    28,200

                  • 0.00

                  • 0.06

                  • AST Schroders Multi-Asset World Strats

                  •  

                    12,600

                  • 0.00

                  • 0.03

                  • Aviva Schroders QEP Global Core

                  •  

                    11,700

                  • 0.00

                  • 0.03

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Sun Pharmaceutical Industries Ltd

                  •  

                    29,497,813

                  • 0.00%

                  • 65.86

                  • IsZo Capital Management LP

                  •  

                    1,104,168

                  • 0.00%

                  • 2.58

                  • Hotchkis & Wiley Capital Management LLC

                  •  

                    510,952

                  • +12.23%

                  • 1.19

                  • Consonance Capital Management LP

                  •  

                    378,372

                  • +37.47%

                  • 0.88

                  • Renaissance Technologies Corp

                  •  

                    371,200

                  • +38.30%

                  • 0.87

                  • Perceptive Advisors LLC

                  •  

                    301,333

                  • +210.62%

                  • 0.70

                  • Greywolf Capital Management LP

                  •  

                    277,936

                  • -1.33%

                  • 0.65

                  • Raging Capital Management LLC

                  •  

                    253,236

                  • -2.46%

                  • 0.59

                  • Bluemountain Capital Management, LLC

                  •  

                    192,389

                  • -59.78%

                  • 0.45

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Speculative Growth

                  Style

                  Mid Growth

                  Taro Pharmaceutical Industries Ltd was incorporated under the laws of the State of Israel in 1959 under the name Taro-Vit Chemical Industries Ltd. In 1984, it changed its name to Taro Vit Industries Ltd. and in 1994 it changed its na...moreme to Taro Pharmaceutical Industries Ltd., which was the name of a subsidiary of Taro Vit Industries Ltd. incorporated under the laws of the State of Israel in 1950. In 1961, the Company completed the initial public offering of its ordinary shares. The Company is a multinational, science-based pharmaceutical company. It develops, manufactures and markets Rx and OTC pharmaceutical products primarily in the United States, Canada and Israel. Its primary areas of focus include semi-solids formulations such as creams and ointments and other dosage forms such as liquids, capsu...moreles and tablets, mainly in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The Company markets more than 200 pharmaceutical products in over 25 countries. The Company competes with the original manufacturers of the brand-name equivalents of its generic products, other generic drug manufacturers including brand-name companies that also manufacture generic drugs or license their products to other generic drug manufacturers and manufacturers of new drugs that may compete with its generic drugs. In Canada, the Company’s competition includes Merck Canada Inc., Pfizer Canada Inc., Janssen Inc., Novartis Pharmaceuticals Canada Inc., GlaxoSmithKline Inc., Valeant Canada, AstraZeneca Canada, Johnson & Johnson Inc., Bayer Inc. and Bristol-Myers Squibb Canada. The Company also competes with other manufacturers of generic products, such as Apotex Inc., Teva Canada Limited, Mylan Pharmaceuticals ULC, Sandoz Canada Incorporated and Pharmascience Inc. In Israel, it competes with Teva Pharmaceutical Industries Ltd., Perrigo Israel Pharmaceuticals Ltd., Dexcel Pharma Israel, and Rafa Laboratories Ltd., among others. In addition, many multinational companies, including Bayer AG, Eli Lilly and Company, Merck & Co., Inc. and Pfizer Inc., market their products in Israel.lessless

                  Key People

                  Mr. Kalyanasundaram Subramanian

                  CEO/Director

                  Mr. Dilip S. Shanghvi

                  Chairman of the Board/Director

                  Mr. Michael Kalb

                  CFO/CFO, Geographical/Chief Accounting Officer

                  Dr. Avi Avramoff

                  Vice President, Divisional

                  Mr. Rami Zajicek

                  Vice President, Divisional

                  • Taro Pharmaceutical Industries Ltd

                  • 14 Hakitor Street

                  • Haifa Bay, 2624761

                  • ISR.Map

                  • Phone: +972 48475700

                  • Fax: +972 48727165

                  • taro.co.il

                  Incorporated

                  1959

                  Employees

                  1,342

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: